Harvard's Dana-Farber Cancer Institute Retracts Six Studies, Corrects 31 Others Amid Data Falsification Allegations

Top researchers, including the institute's CEO, are under scrutiny following claims of data forgery by British molecular biologist Dr. Sholto David.